Loading clinical trials...
Loading clinical trials...
RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute myeloid leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect cha...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT06191978 · Acute Myeloid Leukemia
NCT06317649 · Acute Myeloid Leukemia
NCT06311227 · Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant
NCT06299540 · Leukemia, Lymphocytic, Chronic, B-Cell
Veterans Affairs Medical Center - Birmingham
Birmingham, Alabama
University of California San Diego Cancer Center
La Jolla, California
Veterans Affairs Medical Center - San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions